Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer: Evidence Report/Technology Assessment Number 212 by Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer: Evidence Report/Technology Assessment Number 212

Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

518 pages • missing pub info (view editions)

nonfiction health challenging informative medium-paced
Powered by AI (Beta)
Loading...

Description

Ovarian cancer is the eighth most common cancer in women and is the fifth leading cause of cancer death, with an age-adjusted rate of 8.2 deaths per 100,000 women. Given current age-specific incidence and demographic projections, the number of cas...

Read more

Community Reviews

Loading...

Content Warnings

Loading...